Article
Biologics in psoriasis are a hot buzzword asthe 62nd meeting of the American Academy of Dermatology hits stride today,with sources hailing the progression as a needed "new era." Technicalexhibits open today at 11 a.m. at the Wasington Convention Center, whilethe conference, symposia, and educational programs are in full gear.Dermatologists must enhance patients' understanding of biologics andmake them realize they have an option when other treatment modalities fail,sources added, as leveraging the patient-physician relationship is key.